Geriatr Gerontol Int. 2021 Dec;21(12):1105-1110. doi: 10.1111/ggi.14292. Epub 2021 Oct 15.

Treatment and prognosis of patients with both cancer and impaired decision-patient with both cancer and dementia making as a symptom of dementia.

Geriatrics & gerontology international

Tomomi Fujii, Michiko Wada, Shinji Hasebe, Kazuto Takeuchi, Toshihiro Yorozuya, Yoshihiro Yakushijin

PMID: 34652052 DOI: 10.1111/ggi.14292

Abstract

AIM: In our aging society, the number of patients with both cancer and dementia has recently been increasing. One of the major clinical questions is whether patients with dementia could receive appropriate cancer treatment. The purpose of this study is to know the prognosis of patients with both cancer and impaired decision-making as a symptom of dementia, and to discuss the proper cancer treatment of the patients with dementia.

METHODS: Patients newly diagnosed with both cancer and impaired decision-making as a symptom of dementia at Ehime University Hospital between January 2010 and December 2016 were reviewed. The data of patients with cancer were retrospectively analyzed using an electronic medical record system.

RESULTS: In total, 9354 cases were diagnosed with cancer in the Ehime University Hospital over 7 years, and only 105 (1.1%) cases with impaired decision-making as a symptom of dementia were recorded by medical professionals, probably due to poor attention to the cognitive functions of patients with cancer. Analysis of the cancer prognosis of these patients showed that a better prognosis was seen in patients with any therapeutic interventions than in those with no treatment for the cancer itself. However, the prognosis of patients was not significantly different between standard and non-standard treatments.

CONCLUSIONS: This study suggests that the poor interest of medical professionals in the cognitive function of patients with cancer at the time of diagnosis of cancer and the lack of any guidelines for patients with both cancer and dementia are major problems in our aging society. Geriatr Gerontol Int 2021; 21: 1105-1110.

© 2021 Japan Geriatrics Society.

Keywords: cancer treatment; patient with both cancer and dementia; prognosis

References

1. World Health Organization. Dementia. [Cited May 2019.] Available from URL: https://www.who.int/news-room/facts-in-pictures/detail/dementia - PubMed
2. Folstein MF, Folstein SE, McHugh PR. "Mini-mental status". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12: 189-198. - PubMed
3. Creavin ST, Wisniewski S, Noel-Storr AH et al. Mini-Mental State Examination (MMSE) for the detection of dementia in clinically unevaluated people aged 65 and over in community and primary care populations. Cochrane Database Syst Rev 2016; 13: CD011145. - PubMed
4. Kato S, Simogaki H, Onodera A et al. Preparation of revised Hasegawa's Dementia Scale (HDS-R) (in Japanese). Jpn J Geriatr Psychiatry 1991; 2: 1339-1347. - PubMed
5. Imai Y, Hasegawa K. The revised Hasegawa's Dementia Scale (HDS-R) - evaluation of its usefulness as a screening test for dementia. J Hong Kong Coll Psychiatry 1994; 4: 20-24. https://www.easap.asia/index.php/find-issues/past-issue/item/503-v4n2-9402-p20-24 - PubMed
6. Jeong JW, Kim KW, Lee DY et al. A normative study of the revised Hasegawa Dementia Scale: comparison of demographic influences between the revised Hasegawa Dementia Scale and the Mini-Mental Status Examination. Dement Geriatr Cogn Disord 2007; 24: 288-293. - PubMed
7. Tsai N, Gao ZX. Validity of Hasegawa's Dementia Scale for screening dementia among aged Chinese. Int Psychogeriatr 1989; 1: 145-152. - PubMed
8. Kounnavong S, Soundavong K, Xayavong S et al. Lao language version of the Revised Hasegawa's Dementia Scale. Nagoya J Med Sci 2017; 79: 241-249. - PubMed
9. Saw YM, Than TM, Win EM et al. Myanmar language version of the Revised Hasegawa's Dementia Scale. Nagoya J Med Sci 2018; 80: 435-450. - PubMed
10. Ministry of Health, Labor and Welfare. [Cited Nov 2020.] Available from URL: https://www.mhlw.go.jp/stf/shingi/2r9852000001hi4o-att/2r9852000001hi8n.pdf (in Japanese) - PubMed
11. Nieto ML, Albert SM, Morrow LA, Saxton J. Cognitive status and physical function in older African Americans. J Am Geriatr Soc 2008; 56: 2014-2019. - PubMed
12. Yoon J, Okura T, Tsunoda K et al. Relationship between cognitive function and physical performance in order adults. Jpn J Phys Fitness Sports Med 2010; 59: 313-322. - PubMed
13. Ankri J, Andrieu S, Beaufils B, Grand A, Henrard JC. Beyond the global score of the Zarit Burden Interview: useful dimensions for clinicians. Int J Geriatr Psychiatry 2005; 20: 254-260. - PubMed
14. Mohile SG, Dale W, Somerfield MR et al. Practical assessment and management of vulnerabilities in older patients receiving chemotherapy: ASCO guideline for geriatric oncology. J Clin Oncol 2018; 36: 2326-2347. - PubMed
15. Griffiths AW, Ashley L, Kelley R et al. Decision-making in cancer care for people living with dementia. Psycho-oncology 2020; 29: 1347-1354. - PubMed
16. Sudore RL, Lum HD, You JJ et al. Defining advance care planning for adults: a consensus definition from a multidisciplinary Delphi panel. J Pain Symptom Manage 2017; 53: 821-832.el. - PubMed
17. Sudore RL, Heyland DK, Lum HD et al. Outcomes that define successful advance care planning: a Delphi panel consensus. J Pain Symptom Manage 2018; 55: 245-255.e8. - PubMed
18. Myers J, Cosby R, Gzik D et al. Provider tools for advance care planning and goals of care discussions: a systematic review. Am J Hosp Palliat Care 2018; 35: 1123-1132. - PubMed

MeSH terms

• Cognition
• Decision Making
• Dementia* / diagnosis
• Dementia* / therapy
• Humans
• Neoplasms* / complications
• Neoplasms* / diagnosis
• Neoplasms* / therapy
• Prognosis
• Retrospective Studies

Publication Types

• Journal Article